| Stephanie Joyce Barnum, WHNP-BC | |
|
86th Medical Group, Unit 3215, Apo, AE 09094 | |
| (314) 479-2609 | |
| Not Available |
| Full Name | Stephanie Joyce Barnum |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Women's Health |
| Location | 86th Medical Group, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164741880 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LW0102X | Nurse Practitioner - Women's Health | 0024168793 (Virginia) | Primary |
| Entity Name | Womens Health And Surgery Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497901441 PECOS PAC ID: 8224197306 Enrollment ID: O20081104000438 |
News Archive
In a discovery that could lead to more targeted and effective treatments for certain lung and prostate cancers, researchers at the University of Virginia School of Medicine have identified two new cancer-causing gene mutations - mutations that may be particularly susceptible to cancer-fighting drugs already approved by the federal Food and Drug Administration. One of the gene mutations also may play a key role in early menopause.
Xinqiao Jia will never forget a visitor to her professor's lab at Fudan University in Shanghai, China, when she was working on her master's degree in polymer chemistry and physics.
Laser-induced breakdown spectroscopy (LIBS) is emerging as a fast, cost-efficient method for identifying the total amount and specific compounds that comprise the inorganic component of biomass. Accurate and reliable analysis of these minerals, such as aluminum, calcium, iron, and silicon is essential, as this "ash" can cause problems when converting biomass to hydrocarbon biofuels, as described in a study published in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a "less is more" approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro's research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.
Rates of physical and psychological aggression among couples increased significantly after the implementation of shelter-in-place restrictions at the outset of the COVID-19 pandemic, according to a new study led by Georgia State University researchers.
› Verified 1 days ago
| Entity Name | Privia Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20140603000011 |
News Archive
In a discovery that could lead to more targeted and effective treatments for certain lung and prostate cancers, researchers at the University of Virginia School of Medicine have identified two new cancer-causing gene mutations - mutations that may be particularly susceptible to cancer-fighting drugs already approved by the federal Food and Drug Administration. One of the gene mutations also may play a key role in early menopause.
Xinqiao Jia will never forget a visitor to her professor's lab at Fudan University in Shanghai, China, when she was working on her master's degree in polymer chemistry and physics.
Laser-induced breakdown spectroscopy (LIBS) is emerging as a fast, cost-efficient method for identifying the total amount and specific compounds that comprise the inorganic component of biomass. Accurate and reliable analysis of these minerals, such as aluminum, calcium, iron, and silicon is essential, as this "ash" can cause problems when converting biomass to hydrocarbon biofuels, as described in a study published in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a "less is more" approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro's research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.
Rates of physical and psychological aggression among couples increased significantly after the implementation of shelter-in-place restrictions at the outset of the COVID-19 pandemic, according to a new study led by Georgia State University researchers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Joyce Barnum, WHNP-BC 86th Medical Group, Unit 3215, Apo, AE 09094 Ph: () - | Stephanie Joyce Barnum, WHNP-BC 86th Medical Group, Unit 3215, Apo, AE 09094 Ph: (314) 479-2609 |
News Archive
In a discovery that could lead to more targeted and effective treatments for certain lung and prostate cancers, researchers at the University of Virginia School of Medicine have identified two new cancer-causing gene mutations - mutations that may be particularly susceptible to cancer-fighting drugs already approved by the federal Food and Drug Administration. One of the gene mutations also may play a key role in early menopause.
Xinqiao Jia will never forget a visitor to her professor's lab at Fudan University in Shanghai, China, when she was working on her master's degree in polymer chemistry and physics.
Laser-induced breakdown spectroscopy (LIBS) is emerging as a fast, cost-efficient method for identifying the total amount and specific compounds that comprise the inorganic component of biomass. Accurate and reliable analysis of these minerals, such as aluminum, calcium, iron, and silicon is essential, as this "ash" can cause problems when converting biomass to hydrocarbon biofuels, as described in a study published in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a "less is more" approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro's research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.
Rates of physical and psychological aggression among couples increased significantly after the implementation of shelter-in-place restrictions at the outset of the COVID-19 pandemic, according to a new study led by Georgia State University researchers.
› Verified 1 days ago
Richard Allen Sonnier, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Cmr 402, Apo, AE 09180 Phone: 496-371-867276 | |
Kimberly J Bonts, MSN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-6390 | |
Mr. Aaron Bruce Castle Sr., FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Unit 33100 Box Landstul, Apo, AE 09180 Phone: 314-590-1480 | |
Mrs. Kendra L. Spaulding, ACNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Cmr 402, Apo, AE 09180 Phone: 637-186-8590 | |
Mrs. Heather Maples Mccaleb, MSN, APRN, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Unit 3215, Apo, AE 09094 Phone: 314-479-2360 | |
Lisa K. Floyd, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Psc 2, Building 2121, Apo, AE 09012 Phone: 314-479-2609 | |
Ms. Heather Wheeler Hansen, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Cmr 402, Landstuhl Regional Medical Center, Apo, AE 09180 Phone: 011-496-371865762 |